A simple DNA test using circulating tumour DNA could forecast how advanced breast cancer responds to treatment, enabling earlier switches to options more likely to work,...
Researchers have identified a potential treatment target for triple-negative breast cancer, the most aggressive form of breast cancer. The study found that PUF60 helps cancer cells...
Megestrol, a hot flush drug for breast cancer patients, may also curb tumours when added to standard hormone therapy, an early trial has found. The PIONEER...
HRT (hormone replacement therapy) may not increase breast cancer risk in women with BRCA mutations, new research suggests. Women who inherit harmful mutations in the BRCA1...
Telling women their breast density after screening was linked to higher anxiety and confusion than no notification, an Australian study suggests. Breast density is the proportion...
A new AI model can predict a person’s risk of developing breast cancer up to five years in advance by analysing mammograms. The technology could make...
An overlooked fat-derived hormone may drive higher breast cancer death risk in postmenopausal women with obesity, an analysis suggests. The review identifies oestrone, a form of...
An artificial intelligence model predicts five-year breast cancer risk more accurately than traditional breast density assessment, new research shows. The image-only AI model, called Clairity Breast,...
Roche’s experimental oral drug giredestrant improved disease-free survival after breast cancer surgery in an interim late-stage trial, the company said. A scheduled interim analysis found the...
Researchers are probing why breast cancer patients face lasting fatigue after treatment, with exhaustion affecting up to 90 per cent during therapy. Cancer-related fatigue (CRF) —...
